Poster Networking
Immunothrombosis
Fanny Lassalle
PharmD, PhD
Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, F5900 Lille, France
Lille, Nord-Pas-de-Calais, France
Nicolas Duployez
PharmD, PhD
UMR 9020-UMR-S 1277, Canther, Cancer Heterogeneity, plasticity and resistance to therapies, Institut de Recherche contre le Cancer de Lille, University Lille, CNRS, inserm, CHU-Lille, F-59000 Lille, France
Lille, Nord-Pas-de-Calais, France
Flavien Vincent
MD, PhD
Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, F-59000 Lille, France
Lille, Nord-Pas-de-Calais, France
Antoine Rauch (he/him/his)
Associate Professor
Univ.Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, F-59000 Lille, France
Lille, Nord-Pas-de-Calais, France
Tom Denimal
MD
Univ.Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, F-59000 Lille, France
Lille, Nord-Pas-de-Calais, France
Mickael Rosa
PhD
Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, F5900 Lille, France
Lille, Nord-Pas-de-Calais, France
Bart Staels
PharmD, PhD
Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, F5900 Lille, France
Lille, Nord-Pas-de-Calais, France
Claude Preudhomme
PharmD, PhD
UMR 9020-UMR-S 1277, Canther, Cancer Heterogeneity, plasticity and resistance to therapies, Institut de Recherche contre le Cancer de Lille, University Lille, CNRS, inserm, CHU-Lille, F-59000 Lille, France
Lille, Nord-Pas-de-Calais, France
Sophie Susen, MD, PhD (she/her/hers)
MD, PhD
Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011- EGID, F-59000 Lille, France
Lille, Nord-Pas-de-Calais, France
Eric Van belle
MD, PhD
Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, F5900 Lille, France
Lille, Nord-Pas-de-Calais, France
Annabelle Dupont, Pharm D PhD
PharmD, PhD
Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, F5900 Lille, France
59000 Lille, Nord-Pas-de-Calais, France